phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptide
PDE2A
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN937185
Aperçu rapide pour phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptide (ABIN937185)
Antigène
PDE2A
(phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- CRSQQYPAAR PAEPRGQQVF LKPDEPPPQP CADSLQDALL SLGAVIDIAG
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Pde2 a antibody,
Alternative Names: Pde2a control peptide, Pde2a antibody Blocking Peptide, Anti-Pde2a Blocking Peptide, phosphodiesterase 2A, cGMP-stimulated Blocking Peptide, Pde2 Blocking Peptide, Pde2a2 Blocking Peptide, Pde2a Blocking Peptide, Pde2a, Pdea-2, Pdea 2, Pdea-2 Blocking Peptide, Pdea 2 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
-
Sujet
- The activation of Pde2a induces decreased cAMP accumulation, It is involved in nitric oxide mediated signaling in cardiac fibroblasts.
-
Poids moléculaire
- 104 kDa
Antigène
-
Vous êtes ici:
